2001 - 2010 of 9016 Results
Title
Year
- Evidence for encephalopsin immunoreactivity in interneurones and striosomes of the monkey striatum2018RESTRICTEDTitle: Evidence for encephalopsin immunoreactivity in interneurones and striosomes of the monkey striatumJournal Name: Experimental Brain ResearchPublisher: Springer Science and Business Media LLCVol: 236Issue #: 4Start Page: 955End Page: 961Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00221-018-5191-9Citation Count: 19
- Intracellular Target-Specific Accretion of Cell Penetrating Peptides and Bioportides: Ultrastructural and Biological Correlates2015RESTRICTEDTitle: Intracellular Target-Specific Accretion of Cell Penetrating Peptides and Bioportides: Ultrastructural and Biological CorrelatesJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 27Issue #: 1Start Page: 121End Page: 129Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.5b00529Citation Count: 18
- Resistance of naturally secreted α‐synuclein to proteolysis2014RESTRICTEDTitle: Resistance of naturally secreted α‐synuclein to proteolysisJournal Name: The FASEB JournalPublisher: WileyVol: 28Issue #: 7Start Page: 3146End Page: 3158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.13-245852Citation Count: 18
- Promise and Challenge of β-Lactone Electrophiles to Target Aspartate 12 of Mutant KRASG12D2025RESTRICTEDTitle: Promise and Challenge of β-Lactone Electrophiles to Target Aspartate 12 of Mutant KRASG12DJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 68Issue #: 14Start Page: 15050End Page: 15064Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5c01214Citation Count: 1
- Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)2019RESTRICTEDTitle: Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-010Citation Count: 1
- High priority publications on Parkinson's disease in 20172017RESTRICTEDTitle: High priority publications on Parkinson's disease in 2017Journal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 1Start Page: 8End Page: 10Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(17)30416-7Citation Count: 0
-
OPENTitle: Orientation selective deep brain stimulationJournal Name: Journal of Neural EngineeringPublisher: IOP PublishingVol: 14Issue #: 1Start Page: 016016End Page: 016016Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1088/1741-2552/aa5238Best OA location URL: http://doi.org/10.1088/1741-2552/aa5238Citation Count: 51
-
OPENTitle: Unraveling the intersection of aging and Parkinson’s disease: a collaborative roadmap for advancing research modelsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 28End Page: 28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-025-01239-xBest OA location URL: https://www.nature.com/articles/s41531-025-01239-x_reference.pdfCitation Count: 1
- The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)2013RESTRICTEDTitle: The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 7_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p06.049Citation Count: 2
-
OPENTitle: Mutant Allele-Specific CRISPR Disruption in DYT1 Dystonia Fibroblasts Restores Cell FunctionJournal Name: Molecular Therapy Nucleic AcidsPublisher: Elsevier BVVol: 21Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2020.05.009Best OA location URL: http://www.cell.com/article/S2162253120301359/pdfCitation Count: 13